Returning to the pre-antibiotic era in the critically ill: the XDR problem.
Paterson
David L
DL
Lipman
Jeffrey
J
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003091:Colistin / Q000008:administration & dosage / Q000494:pharmacology; D024901:Drug Resistance, Multiple, Bacterial; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy; D051381:Rats; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology; D018805:Sepsis / Q000188:drug therapy*; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D012293:Rifampin; D003091:Colistin